Published in Dermatol Wochenschr on November 18, 1967
[Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin]. Arch Klin Exp Dermatol (1968) 0.97
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther (2010) 1.83
Effects of two novel cationic staphylococcal proteins (NP-tase and p70)and enterotoxin B on IgE synthesis and interleukin-4 and interferon-gamma production in patients with atopic dermatitis. Br J Dermatol (2000) 1.48
Death due to pulmonary tuberculosis in progressive systemic sclerosis. J Eur Acad Dermatol Venereol (2002) 1.39
HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders to immunosuppressive therapy. Int J Dermatol (1991) 1.39
Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol (1990) 1.33
Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient. J Med Vet Mycol (1997) 1.18
Detection of human soluble Thy-1 in serum by ELISA. Fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tissue Res (1999) 1.18
[Localization of the fibrinolytic activity in the skin]. Arch Klin Exp Dermatol (1966) 1.17
The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res (1998) 1.12
Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol (1996) 1.07
Combination of an island advancement flap and a composite graft for reconstruction of the nasolabial defect. Dermatol Surg (1997) 1.06
Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol (1996) 1.06
Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg (2000) 1.05
A ligand of human thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated thy-1-positive microvascular endothelial cells and fibroblasts. J Invest Dermatol (2000) 1.02
Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA (1991) 0.98
[Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin]. Arch Klin Exp Dermatol (1968) 0.97
[Comparison of skin reactions between animal and man]. Dermatol Monatsschr (1979) 0.97
Case report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis. Mycoses (2001) 0.96
[The localization of the tissue activator of fibrinolysis in dermatoses]. Arch Klin Exp Dermatol (1969) 0.95
Environmentally induced systemic sclerosis-like disorders. Int J Dermatol (1985) 0.94
Aspergillus detection in bronchoscopically acquired material. Significance and interpretation. Mycoses (2001) 0.93
[The localization of the tissue activator of fibrinolysis in skin tumors]. Arch Klin Exp Dermatol (1969) 0.93
Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis Rheum (1994) 0.90
Anaphylactic shock and contact urticaria after the patch test with professional allergens. Allerg Immunol (Leipz) (1976) 0.87
[On the fibrinolytic activity of the skin]. Arch Klin Exp Dermatol (1966) 0.87
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis. Arch Dermatol Res (1998) 0.86
In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test. Mycoses (1999) 0.85
Malignant granular cell tumour with generalized metastases and polymyositis. Acta Derm Venereol (2001) 0.84
Different toxic effects of ouabain and 16-epi-gitoxin on Purkinje fibres and ventricular muscle fibres. Pharmacology (1976) 0.84
Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol (2000) 0.84
Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. Exp Dermatol (2000) 0.84
Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris. Drugs (1995) 0.84
[Electron microscopic studies on the epidermal-dermal junction in lupus erythematosus]. Dermatologica (1972) 0.83
The fibroblast-specific MAb AS02: a novel tool for detection and elimination of human fibroblasts. Cell Tissue Res (1997) 0.83
[Membraneless fibrillar and amorphous granular bodies in lupus erythematosus. Electron microscopic study]. Dermatol Monatsschr (1973) 0.83
Pulmonary nocardiosis with cutaneous involvement mimicking a metastasizing lung carcinoma in a patient with chronic myelogenous leukaemia. Eur J Dermatol (2000) 0.83
Longitudinal case analysis in atopic dermatitis. Acta Derm Venereol (2001) 0.83
[Clinical findings, differential diagnosis and therapy of vulvar lichen sclerosus et atrophicus ("kaurosis") within the scope of sclerosing genital atrophies]. Zentralbl Gynakol (1969) 0.83
Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment. Eur J Clin Pharmacol (1981) 0.83
Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. Eur J Dermatol (1998) 0.83
In vitro activity of lithium succinate against Malassezia furfur. Dermatology (1995) 0.83
Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. Br J Dermatol (1990) 0.82
Squamous cell carcinoma of the skin--histopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol (1998) 0.82
Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. Acta Derm Venereol (2001) 0.82
[The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies]. Acta Biol Med Ger (1973) 0.82
[Electron microscopy studies on the viral pathogenesis of lupus erythematosus]. Dermatol Monatsschr (1972) 0.81
Molecular analysis of different phases in human wound healing. Exp Dermatol (1997) 0.81
[Characterization of lymphocytic infiltrate cells in bullous pemphigoid and pemphigus vulgaris]. Dermatol Monatsschr (1990) 0.81
Comparison of therapeutic and toxic actions of ouabain, gitoxin and 16-epi-gitoxin on isolated atria at different extracellular potassium concentrations. Eur J Pharmacol (1973) 0.81
8-Methoxypsoralen serum levels in poor responders to photochemotherapy. Importance of drug formulation and individual factors. Int J Dermatol (1991) 0.81
Digitalis. Pharmacol Ther (1982) 0.81
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
[Effect of pepstatin A on Candida albicans infection in the mouse]. Dermatol Monatsschr (1990) 0.81
Different relationships between therapeutic and toxic actions of 16-epi-gitoxin, gitoxin and ouabain on isolated cardiac preparations. Eur J Pharmacol (1970) 0.80
Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses (1997) 0.80
Acid lysosomal hydrolases in systemic sclerosis and other connective tissue diseases. Br J Dermatol (1982) 0.80
[Treatment of acne vulgaris with hydrogen peroxide emulsion (L/W)]. Dermatol Monatsschr (1987) 0.80
Chemokine release from activated human dermal microvascular endothelial cells--implications for the pathophysiology of scleroderma? Arch Dermatol Res (2000) 0.79
Differentiation of Candida strains by lectin-mediated agglutination kinetics. Mycoses (2000) 0.79
[Detection of fibrin deposits in lichen ruber planus by immunofluorescence]. Dermatol Monatsschr (1970) 0.79
[Infrared photodocumentation of the superficial venous system of the leg]. Asthet Med (Berl) (1967) 0.79
[Detection of a plasminogen-like substance in healthy human skin]. Dermatol Monatsschr (1969) 0.79
Transforming growth factor-beta controls cell-matrix interaction of microvascular dermal endothelial cells by downregulation of integrin expression. J Invest Dermatol (1996) 0.79
The equatorial fibronectin band (EFB) on human spermatozoa--a diagnostic help for male fertility? Andrologia (1987) 0.79
The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients. Int J Clin Pharmacol Ther (1997) 0.79
In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis. J Rheumatol (1997) 0.79
[Dyskeratotic senile keratoma and warty dyskeratoma]. Hautarzt (1967) 0.79
[The Langerhans cell--its macrophages-analogous function in the triggering of the allergic contact eczema (author's transl)]. Allerg Immunol (Leipz) (1979) 0.78
Silica-induced lupus erythematosus. Acta Derm Venereol (1998) 0.78
Differences in the intracellular killing of proteinase-positive and proteinase-negative Candida albicans strains by granulocytes. Mykosen (1986) 0.78
Detection of basement membrane zone antigens and C3 fragments in the blister fluid of bullous pemphigoid. Br J Dermatol (1980) 0.78
Effects of monochromatic ultraviolet irradiation (300-400 nm) on viability of human white blood cells. Photodermatol Photoimmunol Photomed (1990) 0.78
[Metaplastic reticulosis with eosinophilic leukemoid and final lymphoid cell push stimulating the picture of generalized erythroderma]. Dermatol Wochenschr (1967) 0.78
Allergic and irritant potential of benzoyl peroxide. Contact Dermatitis (1985) 0.78
[Rare and newly described histological variants of cutaneous squamous epithelial carcinoma. Classification by histopathology, cytomorphology and malignant potential]. Hautarzt (2001) 0.78
[Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma?]. Dermatol Monatsschr (1986) 0.78
The small proteoglycan fibromodulin is expressed in mitotic, but not in postmitotic fibroblasts. Mol Cell Biol Res Commun (1999) 0.78
[Histological and ultrastructural findings in histiocytosis gigantocellularis (multicentric reticulohistiocytosis)]. Dermatologica (1973) 0.77
[On the intestinal effect of digitoxin, penta-acetylgitoxin and other acetylgitoxins]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1966) 0.77
Pathogenesis of progressive systemic sclerosis. Int J Dermatol (1986) 0.77
Pathogenetic studies in bullous pemphigoid--review of the literature and our own results. J Dermatol (1984) 0.77
In vitro susceptibility testing of Malassezia furfur against rilopirox. Skin Pharmacol (1997) 0.77
Ultrastructure of macrophage-lymphocyte interaction in purpura pigmentosa progressiva. Dermatologica (1976) 0.77
[Stevens-Johnson syndrome with transition to toxic epidermal necrolysis after carbamazepine administration, heroin and alcohol abuse]. Hautarzt (1999) 0.77
Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris. Eur J Clin Microbiol Infect Dis (1992) 0.77
In vitro analysis of adhesion molecule expression and gel contraction of human granulation fibroblasts. Wound Repair Regen (2006) 0.77
[Sclerosing genital atrophy as the cause of phimosis: kraurosis penis--balanitis xerotica obliterans--lichen sclerosus et atrophicus]. Dtsch Gesundheitsw (1968) 0.77
Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol (1991) 0.77
[Fibrinolytic activity of epithelial cells]. Dermatologica (1971) 0.77
The role of bullous pemphigoid antibodies in dermal-epidermal separation. J Invest Dermatol (1989) 0.77
[Sports-induced infections--an overview]. Wien Med Wochenschr (2002) 0.77
Cutaneous breast angiosarcoma after conserving treatment of breast cancer. Eur J Dermatol (2001) 0.77
Studies on the metabolic pattern of propiverine in urine after single administration. Pharmazie (1988) 0.77
Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations. Acta Biol Med Ger (1975) 0.76
Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability. Dermatology (1998) 0.76
Cardiotoxicity of digitalis. Arch Toxicol Suppl (1986) 0.76
[On the effect of the antifibrinolytic agent p-aminomethylbenzoic acid (PAMBA) on transplantation immunology in mice]. Allerg Asthma (Leipz) (1967) 0.76
[Invasive mold infections in the university clinics of Leipzig in the period from 1992-1994]. Mycoses (1996) 0.76